Feasibility of liver transient elastography with FibroScan using a new probe for obese patients.
about
Clinical applications, limitations and future role of transient elastography in the management of liver disease.Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 1, Principles and Techniques.Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity.Cost-utility analysis of nonalcoholic steatohepatitis screening.Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.Non invasive tools for the diagnosis of liver cirrhosis.Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Noninvasive diagnosis of cirrhosis: a review of different imaging modalities.Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascitesTransient elastography: Kill two birds with one stone?The frequency and determinants of liver stiffness measurement failure: a retrospective study of "real-life" 38,464 examinations.Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly.Overview of screening methods for fatty liver disease in children.Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient.The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver diseaseDiscordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C.CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentEvaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre studyFibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease.Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.Update of liver fibrosis and steatosis with transient elastography (Fibroscan).Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients.Recent advances in imaging hepatic fibrosis and steatosis.Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques.Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis.Noninvasive evaluation of NAFLD.Utilization of FibroScan in clinical practice.Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis.Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)).The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions.Feasibility of liver stiffness measurement in morbidly obese patients undergoing bariatric surgery using XL probe.Transient elastography for the diagnosis of liver fibrosis.
P2860
Q26768262-A2831D3C-1402-479A-B55D-E9F0A212252BQ28079445-E776806A-90A1-485D-ADB2-289F24F1F0F9Q28081275-68F0C54C-211E-471A-8BD9-D712DB6F5B78Q30249400-978A3C33-279A-4832-BD3A-5B6FE4E6CE5EQ30357814-1C8B3C3D-4434-48D3-BF19-1BE7558D15CAQ30385602-CCF6A2F2-BC52-490E-BC5C-B2E0D4544522Q30401022-A9EEDC63-39EF-4D77-A63A-348B21016BE9Q30421450-A627D0C2-C631-4DC7-98A0-020EFB7AA785Q30432576-74E74D00-AC5E-4E86-BCBC-9C9BEAED5A74Q30436164-D72E60DC-9AE5-4BA6-BFAD-EB0FE61404E7Q30445525-01D941F6-9128-44E7-9080-CEAB87B6EB34Q30454363-14341A58-2DF7-4DB6-ABD4-BED5C1E1410BQ34047077-CF433DDF-B10A-4710-A5F2-5DEB264BE121Q34830398-30F597C6-81B7-45EC-8451-AB861F67D570Q35209849-C37E381A-FCB6-4C30-863D-F3DF61198D5DQ35736511-36008E9B-3474-4553-8BFF-E258E843039FQ36404873-6427433A-2B75-4846-A4F6-35E582623DE3Q36577670-319FB7E1-9F42-4548-9CBA-1996DECF13BFQ36812170-A213296C-BD19-4D09-9D72-D6681DF6C7C9Q37100669-9E5FF17E-D24D-4DEF-A86C-4E3C03CA1B1DQ37149657-8568BF9C-4C16-4B6C-AC25-D92CF47EE087Q37246609-1FE855A8-842C-4143-91A1-7996C121AA17Q37257281-875D96CF-7FF0-4927-AF82-0ACE9B9CF70DQ37525649-D239E376-A0D1-4AD3-A6C8-86A9F68F6DE7Q37613375-0B7AB634-C6E2-41B0-B619-FFFC2D6DB080Q37615606-CD04E0EB-51FC-4F2F-AC58-54BE8FE4F0A9Q37636503-20BAE278-8F91-4E41-8696-EBB80A1A27A3Q37839093-7B910380-5E5D-4436-B221-235C09BB72ACQ37995326-E2AA6ECB-AFB9-4EC0-9606-4A97D93C7FDEQ38070696-99F27861-5F33-4833-9359-A518F8E04DBBQ38121935-A00A06A6-0365-4DC5-943C-7D99AD9C9C63Q38141711-E18CE464-CD11-47B1-87F3-228C1152B498Q38180992-0BEED0FF-3838-42E9-9B63-7BD9DF7A58F7Q38297230-A2D8A0E2-1033-48ED-B477-DDF1FDDDDB69Q38494198-B2E06C21-44F8-4164-AD34-F48BB0226347Q38635589-EA4B96EA-4B86-4D44-9AF2-86957E4FB26BQ38656970-5BE74EA4-242B-4784-AF9C-C343326D90EBQ38816018-D971607C-4308-4AA1-9CBE-6D6EA2F7FAD2Q39679345-C53D8D49-AF84-4C69-9D67-5EEBBBCEF3F8Q39820612-FA6659F6-C85F-4A28-9D2D-9F194A815335
P2860
Feasibility of liver transient elastography with FibroScan using a new probe for obese patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Feasibility of liver transient ...... new probe for obese patients.
@en
Feasibility of liver transient ...... new probe for obese patients.
@nl
type
label
Feasibility of liver transient ...... new probe for obese patients.
@en
Feasibility of liver transient ...... new probe for obese patients.
@nl
prefLabel
Feasibility of liver transient ...... new probe for obese patients.
@en
Feasibility of liver transient ...... new probe for obese patients.
@nl
P2093
P1433
P1476
Feasibility of liver transient ...... new probe for obese patients.
@en
P2093
Farid El-Hajbi
Julien Vergniol
Juliette Foucher
Victor de Lédinghen
Vincent Rigalleau
Wassil Merrouche
P304
P356
10.1111/J.1478-3231.2010.02258.X
P577
2010-05-14T00:00:00Z